Skip to content

Prevention of excessive vaginal bleeding after vaginal using misoprostol

Prevention of Post Partum Haemorrhage: Role of self administered misoprostol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201303000459148
Enrollment
2400
Registered
2012-11-19
Start date
2012-12-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Post Partum Haemorrhage

Interventions

Miso Arm
control (no drugs offered)

Sponsors

Makerere University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Attending antenatal during study period Pregnancy 28 weeks of amenorrhae and more Willing to be visited at home on the third day after baby by research assistant. Able and willing to give informed consent Resident within the study district

Exclusion criteria

Exclusion criteria: Previous caesarian section Planned caesarian section delivery Blood pressure more than 140 mm of Hg systolic and 90 mm of Hg diastolic recorded twice at interval 1 hour Hemoglobin level less than 8 gms% Multiple pregnancy Known history of bronchial asthma Prior enrollment in this study during previous pregnancy High risk conditions including: diabetes, cardiac ailments, seizures, placenta praevia or anticipated breech delivery. Absence of fetal heart sounds History of known drug allergies Episodes of ante partum bleeding during the current pregnancy

Design outcomes

Primary

MeasureTime frame
more than 500ml of blood loss after vaginal births;pre-delivery Hemoglobin change

Secondary

MeasureTime frame
Transfer to health facility or higher health facility;Blood transfusion;Fluid replacement;Surgical Treatment of PPH;maternal Death

Countries

Uganda

Contacts

Public Contactsam Ononge
ononge2006@yahoo.com256772486301

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026